{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T08:24:55Z","timestamp":1791015895521,"version":"4.1.0"},"reference-count":86,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2021,3,8]],"date-time":"2021-03-08T00:00:00Z","timestamp":1615161600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>New-onset diabetes mellitus after transplantation (NODAT) is a frequent complication in kidney allograft recipients. It may be caused by modifiable and non-modifiable factors. The non-modifiable factors are the same that may lead to the development of type 2 diabetes in the general population, whilst the modifiable factors include peri-operative stress, hepatitis C or cytomegalovirus infection, vitamin D deficiency, hypomagnesemia, and immunosuppressive medications such as glucocorticoids, calcineurin inhibitors (tacrolimus more than cyclosporine), and mTOR inhibitors. The most worrying complication of NODAT are major adverse cardiovascular events which represent a leading cause of morbidity and mortality in transplanted patients. However, NODAT may also result in progressive diabetic kidney disease and is frequently associated with microvascular complications, eventually determining blindness or amputation. Preventive measures for NODAT include a careful assessment of glucose tolerance before transplantation, loss of over-weight, lifestyle modification, reduced caloric intake, and physical exercise. Concomitant measures include aggressive control of systemic blood pressure and lipids levels to reduce the risk of cardiovascular events. Hypomagnesemia and low levels of vitamin D should be corrected. Immunosuppressive strategies limiting the use of diabetogenic drugs are encouraged. Many hypoglycemic drugs are available and may be used in combination with metformin in difficult cases. In patients requiring insulin treatment, the dose and type of insulin should be decided on an individual basis as insulin requirements depend on the patient\u2019s diet, amount of exercise, and renal function.<\/jats:p>","DOI":"10.3390\/medicina57030250","type":"journal-article","created":{"date-parts":[[2021,3,8]],"date-time":"2021-03-08T04:01:25Z","timestamp":1615176085000},"page":"250","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":53,"title":["New-Onset Diabetes after Kidney Transplantation"],"prefix":"10.3390","volume":"57","author":[{"given":"Claudio","family":"Ponticelli","sequence":"first","affiliation":[{"name":"Nephrology, Dialysis and Transplantation, Fondazione IRCCS Ca\u2019 Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6465-428X","authenticated-orcid":false,"given":"Evaldo","family":"Favi","sequence":"additional","affiliation":[{"name":"Renal Transplantation, Fondazione IRCCS Ca\u2019 Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy"},{"name":"Department of Clinical Sciences and Community Health, Universit\u00e0 Degli Studi di Milano, 20122 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3410-9090","authenticated-orcid":false,"given":"Mariano","family":"Ferraresso","sequence":"additional","affiliation":[{"name":"Renal Transplantation, Fondazione IRCCS Ca\u2019 Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy"},{"name":"Department of Clinical Sciences and Community Health, Universit\u00e0 Degli Studi di Milano, 20122 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,3,8]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.transproceed.2010.09.105","article-title":"Significant improvement in patient survival after renal transplantation in the last decade","volume":"43","author":"Favi","year":"2011","journal-title":"Transplant Proc."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/j.transproceed.2010.03.078","article-title":"Evolution of causes of mortality in renal transplantation in the last 10 years","volume":"42","author":"Salerno","year":"2010","journal-title":"Transplant Proc."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1007\/s10157-019-01740-7","article-title":"Causes of late transplant failure in cyclosporine-treated kidney allograft recipients","volume":"23","author":"Moroni","year":"2019","journal-title":"Clin. Exp. Nephrol."},{"key":"ref_4","first-page":"SS41-5","article-title":"Evolution and etiology of cardiovascular diseases in renal transplant recipients","volume":"70","author":"Wheeler","year":"2000","journal-title":"Transplantation"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1177\/152692480201200411","article-title":"Prevalence of cardiovascular risk factors before kidney transplantation","volume":"12","author":"Rice","year":"2002","journal-title":"Prog. Transplant."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/tri.12413","article-title":"Cardiovascular morbidity and mortality after kidney transplantation","volume":"28","author":"Stoumpos","year":"2015","journal-title":"Transpl. Int."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"116","DOI":"10.23876\/j.krcp.18.0068","article-title":"Outcomes of end-stage renal disease patients on the waiting list for deceased donor kidney transplantation: A single-center study","volume":"38","author":"Jeon","year":"2019","journal-title":"Kidney Res. Clin. Pract."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1046\/j.1523-1755.2002.00121.x","article-title":"Ischemic heart disease after renal transplantation","volume":"61","author":"Kasiske","year":"2002","journal-title":"Kidney Int."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/ki.2014.335","article-title":"Cardiovascular risk assessment in kidney transplantation","volume":"87","author":"Hart","year":"2015","journal-title":"Kidney Int."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1159\/000495081","article-title":"Trends in the Causes of Death among Kidney Transplant Recipients in the United States (1996\u20132014)","volume":"48","author":"Awan","year":"2018","journal-title":"Am. J. Nephrol."},{"key":"ref_11","first-page":"1992","article-title":"Proceedings From an International Consensus Meeting on Posttransplantation Diabetes Mellitus: Recommendations and Future Directions","volume":"14","author":"Sharif","year":"2014","journal-title":"Arab. Archaeol. Epigr."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"American Diabetes Association 2 (2020). Classification and diagnosis of diabetes: Standards of medical care in diabetes\u20142020. Diabetes Care, 43, S14\u2013S31.","DOI":"10.2337\/dc20-S002"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Davidson, J., Wilkinson, A., Dantal, J., Dotta, F., Haller, H., Hernandez, D., Kasiske, B.L., Kiberd, B., Krentz, A., and Legendre, C. (2003, January 19). New-onset diabetes after transplantation: 2003 International consensus guidelines. Proceedings of the International Expert Panel Meeting, Barcelona, Spain.","DOI":"10.1097\/01.TP.0000069952.49242.3E"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"175","DOI":"10.2147\/DMSO.S19027","article-title":"New onset diabetes after transplantation (NODAT): An overview","volume":"4","author":"Pham","year":"2011","journal-title":"Diabetes Metab Syndr Obes."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"132","DOI":"10.4239\/wjd.v9.i7.132","article-title":"New-onset diabetes after kidney transplantation: Incidence and associated factors","volume":"9","author":"Gomes","year":"2018","journal-title":"World J. Diabetes"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/s41574-018-0137-7","article-title":"Post-transplant diabetes mellitus in patients with solid organ transplants","volume":"15","author":"Jenssen","year":"2019","journal-title":"Nat. Rev. Endocrinol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1097\/01.smj.0000209366.91803.99","article-title":"Perioperative Glucose Control in the Diabetic or Nondiabetic Patient","volume":"99","author":"Smiley","year":"2006","journal-title":"South. Med. J."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s11154-017-9440-1","article-title":"Hepatitis C virus infection and development of type 2 diabetes mellitus: Systematic review and meta-analysis of the literature","volume":"19","author":"Fabiani","year":"2018","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1093\/ndt\/gfi033","article-title":"Is there a link between cytomegalovirus infection and new-onset posttransplantation diabetes mellitus? Potential mechanisms of virus induced \u03b2-cell damage","volume":"20","author":"Jenssen","year":"2005","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_20","first-page":"173","article-title":"Correlation between CMV Infection and Post-transplantation New-onset Diabetes Mellitus","volume":"7","author":"Laca","year":"2016","journal-title":"Int. J. Organ Transplant. Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1373\/clinchem.2012.193003","article-title":"Low 25-Hydroxyvitamin D and Risk of Type 2 Diabetes: A Prospective Cohort Study and Metaanalysis","volume":"59","author":"Afzal","year":"2013","journal-title":"Clin. Chem."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.2337\/dc12-0962","article-title":"Blood 25-Hydroxy Vitamin D Levels and Incident Type 2 Diabetes: A meta-analysis of prospective studies","volume":"36","author":"Song","year":"2013","journal-title":"Diabetes Care"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1681\/ASN.2015040391","article-title":"Hypomagnesemia and the Risk of New-Onset Diabetes Mellitus after Kidney Transplantation","volume":"27","author":"Huang","year":"2016","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ecl.2013.10.005","article-title":"Mechanisms of Glucocorticoid-Induced Insulin Resistance","volume":"43","author":"Geer","year":"2014","journal-title":"Endocrinol. Metab. Clin. North Am."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/MED.0b013e3283444b09","article-title":"Obesity, insulin resistance and free fatty acids","volume":"18","author":"Boden","year":"2011","journal-title":"Curr. Opin. Endocrinol. Diabetes Obes."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/00075197-199903000-00011","article-title":"Pathways of muscle protein breakdown in injury and sepsis","volume":"2","author":"Hasselgren","year":"1999","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1111\/1753-0407.12645","article-title":"Diabetes and branched-chain amino acids: What is the link?","volume":"10","author":"Bloomgarden","year":"2018","journal-title":"J. Diabetes"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1002\/bies.20151","article-title":"Insulin and its receptor: Structure, function and evolution","volume":"26","year":"2004","journal-title":"BioEssays"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"3854","DOI":"10.1172\/JCI66180","article-title":"New mechanisms of glucocorticoid-induced insulin resistance: Make no bones about it","volume":"122","author":"Ferris","year":"2012","journal-title":"J. Clin. Investig."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"4172","DOI":"10.1172\/JCI63377","article-title":"Osteoblasts mediate the adverse effects of glucocorticoids on fuel metabolism","volume":"122","author":"Henneicke","year":"2012","journal-title":"J. Clin. Investig."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.2337\/diabetes.54.4.1090","article-title":"Serum- and Glucocorticoid-Inducible Kinase 1 (SGK1) Mediates Glucocorticoid-Induced Inhibition of Insulin Secretion","volume":"54","author":"Ullrich","year":"2005","journal-title":"Diabetes"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.metabol.2005.06.023","article-title":"Dexamethasone suppresses phospholipase C activation and insulin secretion from isolated rat islets","volume":"55","author":"Zawalich","year":"2006","journal-title":"Metabolism"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1007\/s40620-019-00602-5","article-title":"Prevention of complications from use of conventional immunosuppressants: A critical review","volume":"32","author":"Ponticelli","year":"2019","journal-title":"J. Nephrol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/j.1476-5381.2010.01018.x","article-title":"Cyclosporin and tacrolimus impair insulin secretion and transcriptional regulation in INS-1E beta-cells","volume":"162","author":"Ozbay","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1002\/cpt.546","article-title":"Calcineurin Inhibitors: Pharmacologic Mechanisms Impacting Both Insulin Resistance and Insulin Secretion Leading to Glucose Dysregulation and Diabetes Mellitus","volume":"101","author":"Chakkera","year":"2017","journal-title":"Clin. Pharmacol. Ther."},{"key":"ref_36","first-page":"3240","article-title":"Inhibition of the mTOR pathway: A new mechanism of \u03b2 cell toxicity induced by tacrolimus","volume":"19","author":"Rovira","year":"2019","journal-title":"Arab. Archaeol. Epigr."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Li, Z., Sun, F., Zhang, Y., Chen, H., He, N., Chen, H., Song, P., Wang, Y., Yan, S., and Zheng, S. (2015). Tacrolimus Induces Insulin Resistance and Increases the Glucose Absorption in the Jejunum: A Potential Mechanism of the Diabetogenic Effects. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0143405"},{"key":"ref_38","first-page":"2829","article-title":"Deciphering Tacrolimus-Induced Toxicity in Pancreatic \u03b2 Cells","volume":"17","author":"Wagner","year":"2017","journal-title":"Arab. Archaeol. Epigr."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1681\/ASN.2007111202","article-title":"Sirolimus Is Associated with New-Onset Diabetes in Kidney Transplant Recipients","volume":"19","author":"Johnston","year":"2008","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"2674","DOI":"10.2337\/db13-0106","article-title":"Evidence for Rapamycin Toxicity in Pancreatic \u03b2-Cells and a Review of the Underlying Molecular Mechanisms","volume":"62","author":"Barlow","year":"2013","journal-title":"Diabetes"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1097\/TP.0000000000001722","article-title":"mTOR and Cardiovascular Diseases","volume":"102","year":"2018","journal-title":"Transplantation"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1126\/science.1215135","article-title":"Rapamycin-Induced Insulin Resistance Is Mediated by mTORC2 Loss and Uncoupled from Longevity","volume":"335","author":"Lamming","year":"2012","journal-title":"Science"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"261","DOI":"10.2165\/00063030-200115040-00006","article-title":"Risk Factors for and Management of Post-Transplantation Cardiovascular Disease","volume":"15","year":"2001","journal-title":"BioDrugs"},{"key":"ref_44","first-page":"593","article-title":"Patient Survival and Cardiovascular Risk after Kidney Transplantation: The Challenge of Diabetes","volume":"8","author":"Cosio","year":"2008","journal-title":"Arab. Archaeol. Epigr."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"iv39","DOI":"10.1093\/ndt\/gfs544","article-title":"Risk factors for graft loss and mortality after renal transplantation according to recipient age: A prospective multicentre study","volume":"27","author":"Morales","year":"2012","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_46","first-page":"178","article-title":"Diabetes Mellitus after Kidney Transplantation in the United States","volume":"3","author":"Kasiske","year":"2003","journal-title":"Arab. Archaeol. Epigr."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"445","DOI":"10.4239\/wjd.v6.i3.445","article-title":"New-onset diabetes mellitus after kidney transplantation: Current status and future directions","volume":"6","author":"Palepu","year":"2015","journal-title":"World J. Diabetes"},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Cheng, C.-Y., Chen, C.-H., Wu, M.-F., Wu, M.-J., Chen, J.-P., Liu, Y.-M., Hou, Y.-C., and Wang, H.-Y. (2020). Risk Factors in and Long-Term Survival of Patients with Post-Transplantation Diabetes Mellitus: A Retrospective Cohort Study. Int. J. Environ. Res. Public Heal., 17.","DOI":"10.3390\/ijerph17124581"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"625","DOI":"10.2337\/dc18-1936","article-title":"Occurrence of Diabetic Nephropathy After Renal Transplantation Despite Intensive Glycemic Control: An Observational Cohort Study","volume":"42","author":"Coemans","year":"2019","journal-title":"Diabetes Care"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.semnephrol.2007.01.012","article-title":"Histopathology of Diabetic Nephropathy","volume":"27","author":"Fioretto","year":"2007","journal-title":"Semin. Nephrol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"814","DOI":"10.2215\/CJN.04681107","article-title":"Impact of Acute Rejection and New-Onset Diabetes on Long-Term Transplant Graft and Patient Survival","volume":"3","author":"Cole","year":"2008","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_52","first-page":"15224502","article-title":"Role of advanced glycation end products (AGEs) and their receptor (RAGE) in the pathogenesis of diabetic microangiopathy","volume":"23","author":"Yamagishi","year":"2003","journal-title":"Int. J. Clin. Pharmacol. Res."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.numecd.2013.04.004","article-title":"AGEs, rather than hyperglycemia, are responsible for microvascular complications in diabetes: A \u201cglycoxidation-centric\u201d point of view","volume":"23","author":"Chilelli","year":"2013","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1152\/physrev.00045.2011","article-title":"Mechanisms of Diabetic Complications","volume":"93","author":"Forbes","year":"2013","journal-title":"Physiol. Rev."},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Peev, V., Reiser, J., and Alachkar, N. (2014). Diabetes Mellitus in the Transplanted Kidney. Front. Endocrinol., 5.","DOI":"10.3389\/fendo.2014.00141"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"142","DOI":"10.3109\/07435800.2015.1094088","article-title":"Hypomagnesemia linked to new-onset diabetes mellitus after kidney transplantation: A systematic review and meta-analysis","volume":"41","author":"Cheungpasitporn","year":"2016","journal-title":"Endocr. Res."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1586\/1744666X.2014.949674","article-title":"Vitamin D: A new player in kidney transplantation?","volume":"10","author":"Ponticelli","year":"2014","journal-title":"Expert Rev. Clin. Immunol."},{"key":"ref_58","first-page":"207","article-title":"Vitamin D deficiency is an independent risk factor for PTDM after kidney transplantation","volume":"29","author":"Fournier","year":"2015","journal-title":"Transpl. Int."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"3289","DOI":"10.1210\/jc.2011-0657","article-title":"Approach to the Patient with New-Onset Diabetes after Transplant (NODAT)","volume":"96","author":"Lane","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1093\/ndt\/5.3.220","article-title":"Post-Transplant Diabetes Mellitus in Renal Allograft Recipients: A Matched-Pair Control Study","volume":"5","author":"Frei","year":"1990","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"65","DOI":"10.2169\/internalmedicine.9013-17","article-title":"The Effects of Mitiglinide and Repaglinide on Postprandial Hyperglycemia in Patients Undergoing Methylprednisolone Pulse Therapy","volume":"57","author":"Tanaka","year":"2018","journal-title":"Intern. Med."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1517\/14656566.2011.628936","article-title":"Prevention and management of transplant-associated diabetes","volume":"12","author":"Jenssen","year":"2011","journal-title":"Expert Opin. Pharmacother."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1053\/j.ajkd.2004.03.020","article-title":"New-onset diabetes mellitus in transplant patients: Pathogenesis, complications, and management","volume":"43","author":"Markell","year":"2004","journal-title":"Am. J. Kidney Dis."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1093\/ndt\/gfx281","article-title":"New-onset diabetes after kidney transplantation: Can the risk be modified by choosing immunosuppression regimen based on pretransplant viral serology?","volume":"33","author":"Santos","year":"2018","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1097\/TP.0b013e318203c25f","article-title":"New-Onset Diabetes Mellitus in Kidney Transplant Recipients Discharged on Steroid-Free Immunosuppression","volume":"91","author":"Luan","year":"2011","journal-title":"Transplantation"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1016\/j.ekir.2018.07.009","article-title":"Randomized Controlled Trial Assessing the Impact of Tacrolimus Versus Cyclosporine on the Incidence of Posttransplant Diabetes Mellitus","volume":"3","author":"Torres","year":"2018","journal-title":"Kidney Int. Rep."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1053\/j.ajkd.2016.09.021","article-title":"Safety and Efficacy Outcomes 3 Years After Switching to Belatacept From a Calcineurin Inhibitor in Kidney Transplant Recipients: Results From a Phase 2 Randomized Trial","volume":"69","author":"Rial","year":"2017","journal-title":"Am. J. Kidney Dis."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"e350","DOI":"10.1097\/TXD.0000000000000767","article-title":"Improved Glucose Tolerance in a Kidney Transplant Recipient With Type 2 Diabetes Mellitus After Switching From Tacrolimus To Belatacept: A Case Report and Review of Potential Mechanisms","volume":"4","author":"Baan","year":"2018","journal-title":"Transplant. Direct"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/S2213-8587(18)30025-1","article-title":"Do sulphonylureas still have a place in clinical practice?","volume":"6","author":"Khunti","year":"2018","journal-title":"Lancet Diabetes Endocrinol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1007\/s00592-018-1137-8","article-title":"Post-transplantation diabetes in kidney transplant recipients: An update on management and prevention","volume":"55","author":"Conte","year":"2018","journal-title":"Acta Diabetol."},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Corremans, R., Vervaet, B.A., D\u2019Haese, P.C., Neven, E., and Verhulst, A. (2018). Metformin: A Candidate Drug for Renal Diseases. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20010042"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1159\/000481951","article-title":"Renoprotective Effects of Metformin","volume":"138","author":"Kajbaf","year":"2018","journal-title":"Nephron"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1159\/000370034","article-title":"Metformin Use in Kidney Transplant Recipients in the United States: An Observational Study","volume":"40","author":"Stephen","year":"2014","journal-title":"Am. J. Nephrol."},{"key":"ref_74","first-page":"CD002967","article-title":"Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus","volume":"2010","author":"Salpeter","year":"2010","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1177\/2040622318779760","article-title":"Assessing the incidence of acidosis in patients receiving metformin with and without risk factors for lactic acidosis","volume":"9","author":"Trinkley","year":"2018","journal-title":"Ther. Adv. Chronic Dis."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1097\/01.tp.0000181165.19788.95","article-title":"Rosiglitazone Therapy of Posttransplant Diabetes Mellitus","volume":"80","author":"Villanueva","year":"2005","journal-title":"Transplant."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.ejmech.2016.12.020","article-title":"Thiazolidinediones and PPAR orchestra as antidiabetic agents: From past to present","volume":"126","author":"Yasmin","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1093\/ndt\/gfy407","article-title":"SGLT-2 inhibitors and GLP-1 receptor agonists for nephroprotection and cardioprotection in patients with diabetes mellitus and chronic kidney disease. A consensus statement by the EURECA-m and the DIABESITY working groups of the ERA-EDTA","volume":"34","author":"Sarafidis","year":"2019","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJMoa1603827","article-title":"Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0140-6736(19)31150-X","article-title":"Dulaglutide and renal outcomes in type 2 diabetes: An exploratory analysis of the REWIND randomised, placebo-controlled trial","volume":"394","author":"Gerstein","year":"2019","journal-title":"Lancet"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"S245","DOI":"10.2337\/dcS13-2004","article-title":"Do GLP-1 based therapies increase cancer risk?","volume":"36","author":"Nauck","year":"2013","journal-title":"Diabetes Care"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1080\/14740338.2018.1444027","article-title":"The safety of gliptins: Updated data in 2018","volume":"17","author":"Scheen","year":"2018","journal-title":"Expert Opin. Drug Saf."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1056\/NEJMoa1811744","article-title":"Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy","volume":"380","author":"Perkovic","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/S2213-8587(19)30180-9","article-title":"Effects of dapagliflozin on development and progression of kidney disease in patients with type 2 diabetes: An analysis from the DECLARE\u2013TIMI 58 randomised trial","volume":"7","author":"Mosenzon","year":"2019","journal-title":"Lancet Diabetes Endocrinol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1159\/000501854","article-title":"Sodium-Glucose Cotransporter 2 (SGLT2) Inhibition in Kidney Transplant Recipients with Diabetes Mellitus","volume":"44","author":"Mahling","year":"2019","journal-title":"Kidney Blood Press. Res."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"278","DOI":"10.4103\/ijn.IJN_2_18","article-title":"Efficacy and Safety of Canagliflozin in Kidney Transplant Patients","volume":"29","author":"Shah","year":"2019","journal-title":"Indian J. Nephrol."}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/57\/3\/250\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T05:34:38Z","timestamp":1760160878000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/57\/3\/250"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,8]]},"references-count":86,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2021,3]]}},"alternative-id":["medicina57030250"],"URL":"https:\/\/doi.org\/10.3390\/medicina57030250","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,8]]}}}